Is there any benefit to extending the dosing interval of ixekizumab in patients with stable psoriasis?

Featuring Tina Bhutani, MD, MAS | CEO, Synergy Dermatology Associate Clinical Professor of Dermatology University of California, SF San Francisco, CA | Published October 18, 2024